Posted by Michael Wonder on 01 Dec 2022
‘Good news’ for Kiwi women as PHARMAC funds Utrogestan from today
1 December 2022 - The end of a decade long wait.
Pharmaco welcomes the start of PHARMAC funding for Utrogestan (micronised progesterone), which begins today. The funding means thousands of Kiwi women now have access to this medication, which when combined with an oestrogen can help reduce menopausal symptoms.
